You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

TNBC

Showing 1 - 25 of 635
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TNBC - Triple-Negative Breast Cancer Trial (Camrelizumab Plus Chemotherapy and Famitinib, Camrelizumab Plus Chemotherapy)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Camrelizumab Plus Chemotherapy and Famitinib
  • Camrelizumab Plus Chemotherapy
  • (no location specified)
Aug 17, 2023

TNBC Trial in Shanghai (PM8002, nab-paclitaxel)

Recruiting
  • TNBC
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Jun 25, 2023

TNBC - Triple-Negative Breast Cancer Trial (A1:SG with SHR3680, A2:SG, B1:SG with SHR1210)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • A1:SG with SHR3680
  • +7 more
  • (no location specified)
Jun 23, 2023

BRCA and NACT in TNBC Patients

Completed
  • Triple-Negative Breast Cancer
  • BRCA1/2 genetic testing
  • Rome, RM, Italy
    Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Feb 20, 2023

Breast Cancer, Contrast Enhanced Ultrasound Trial in Hershey (Lumason)

Not yet recruiting
  • Breast Cancer
  • Contrast Enhanced Ultrasound
  • Hershey, Pennsylvania
    Penn State Health College of Medicine
Jul 19, 2023

TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial (Pembrolizumab, Radiation Therapy, Axatilimab)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Breast Cancer
  • (no location specified)
Aug 4, 2022

Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

Not yet recruiting
  • Triple Negative Breast Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 25, 2023

Breast Cancer Trial in Houston (Sacituzumab Govitecan, Pembrolizumab)

Not yet recruiting
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Dec 22, 2022

Immunotherapy-related CRP Kinetics in Early and Metastatic

Recruiting
  • TNBC - Triple-Negative Breast Cancer
    • Tuebingen, Germany
      Department of Women's Health
    Jun 13, 2023

    Triple Negative Breast Cancer (TNBC) Trial in El Segundo (Leucovorin, 5-Fluorouracil, Aldoxorubicin HCl)

    Withdrawn
    • Triple Negative Breast Cancer (TNBC)
    • El Segundo, California
      Chan Soon-Shiong Institute for Medicine
    Mar 28, 2022

    Triple Negative Breast Cancer, HER2-negative Breast Cancer Trial in Tampa (HER2 - primed Dendritic cells, HER3 - primed

    Recruiting
    • Triple Negative Breast Cancer
    • HER2-negative Breast Cancer
    • HER2 - primed Dendritic cells
    • HER3 - primed Dendritic cells
    • Tampa, Florida
      Moffitt Cancer Center
    Jan 10, 2023

    Metastatic Triple-negative Breast Cancer Trial in Italy (Tissue Immune Profile)

    Recruiting
    • Metastatic Triple-negative Breast Cancer
    • Tissue Immune Profile
    • Prato, FI, Italy
    • +6 more
    Apr 14, 2023

    TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

    Not yet recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Alkaline Glucosodiene Molecules
    • (no location specified)
    Jul 14, 2023

    Brain Metastases, Tumor Trial in Houston (Pembrolizumab, Lenvatinib)

    Recruiting
    • Brain Metastases
    • Tumor
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 8, 2022

    Triple Negative Breast Cancer Trial in Chengdu (Camrelizumab, Apatinib, Nab-paclitaxel)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Chengdu, Sichuan, China
      West China Hospital, Sichuan University
    Jul 6, 2022

    Epidemiology of TNBC in Asyut Clinical Oncology Department

    Not yet recruiting
    • Breast Cancer
      • (no location specified)
      Oct 15, 2022

      Triple Negative Breast Cancer Trial in El Segundo (drug, biological, procedure)

      Active, not recruiting
      • Triple Negative Breast Cancer
      • Aldoxorubicin HCl
      • +17 more
      • El Segundo, California
        Chan Soon-Shiong Institute for Medicine
      Mar 28, 2022

      Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

      Recruiting
      • Breast Cancer
      • +9 more
      • Boston, Massachusetts
      • +2 more
      Oct 25, 2022

      Triple-negative Breast Cancer Trial (Pembrolizumab 25 mg/ml, Paclitaxel injection)

      Not yet recruiting
      • Triple-negative Breast Cancer
      • Pembrolizumab 25 mg/ml
      • Paclitaxel injection
      • (no location specified)
      Oct 11, 2023

      Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)

      Recruiting
      • Triple Negative Breast Cancer
      • Breast Cancer
      • Fairway, Kansas
      • +5 more
      Jan 26, 2023

      Breast Tumor Trial (Trilaciclib plus chemo, Chemotherapy)

      Not yet recruiting
      • Breast Neoplasm
      • (no location specified)
      May 8, 2023

      Triple Negative Breast Tumors Trial in Paris (Atezolizumab + RP1)

      Not yet recruiting
      • Triple Negative Breast Neoplasms
      • Atezolizumab + RP1
      • Paris, France
        Institut Curie
      Oct 2, 2023

      Metastatic Breast Cancer Trial in Shanghai (Sitravatinib, Tislelizumab, Nab-paclitaxel)

      Recruiting
      • Metastatic Breast Cancer
      • Shanghai, Shanghai, China
        Fudan University Shanghai Cancer
      Jul 31, 2022

      Breast Cancer, Triple-Negative Breast Cancer Trial in Guangzhou, Nanjing, Shanghai (Anti-PD-1 mAb, VEGFR2 Tyrosine Kinase

      Recruiting
      • Breast Cancer
      • Triple-Negative Breast Cancer
      • Anti-PD-1 monoclonal antibody
      • VEGFR2 Tyrosine Kinase Inhibitor
      • Guangzhou, Guangdong, China
      • +2 more
      Sep 24, 2022

      Breast Cancer, Triple Negative Breast Cancer Trial (Antivascular therapy, Chemotherapy)

      Not yet recruiting
      • Breast Cancer
      • Triple Negative Breast Cancer
      • (no location specified)
      Jun 11, 2023